The role of vitamin D and its supplementation in sarcoidosis – current status

Anna Bieda
ID
Email src
Monika Kondracka
ID
Michał Bielecki
ID
Agata Zapałowska
ID
Kamil Kondracki
ID
Milena Szczepańska
ID
Wojciech Kozłowski
ID
Masovian Bródnowski Hospital, Warsaw, Poland
Prague Hospital of Lord’s Transfiguration, Warsaw, Poland
The Independent Group of Public Ambulatory Care Institutions Warsaw-Mokotów, Warsaw, Poland
John Paul II Independent Public Specialist Western Hospital, Grodzisk Mazowiecki, Poland
Medical Center named after the Battle of Warsaw 1920 in Radzymin Independent Public Health Care Facility Complex, Radzymin, Poland
Independent Clinical Hospital named after Prof. Witold Orlowski in Warsaw, Warsaw, Poland
Marynin Medical Center, Marynin, Poland
Received: 25 November 2024 / Revised: 7 January 2025 / Accepted: 25 January 2025 / Published: 30 June 2025

Abstract

Introduction and aim. Sarcoidosis is a chronic autoimmune-related inflammatory disease characterized by non-caseating granuloma formation. The macrophages accumulating in granulomas express increased 1alpha hydroxylase activity. Increased extrarenal 1,25-dihydroxyvitamin D synthesis can lead to hypercalcemia and its complications. However, 25-hydroxyvitamin D deficiency and insufficiency are virtually universal among sarcoidosis patients. The aim of this study was to explain the complex role of vitamin D and to its metabolites and discuss the possible benefits and risks associated with the administration of exogenous vitamin D to patients with sarcoidosis.

Material and methods. PubMed and Scopus databases were searched for reviews about The role of vitamin D and its supplementation in sarcoidosis. The authors have analyzed a total of 107 full-text articles published between January 2000 and November 2024, with additional articles identified by bibliography analysis.

Analysis of literature. The potential benefits of vitamin D supplementation in sarcoidosis are promising in terms of reducing the inflammatory response, counteracting disease progression, reducing bone fracture risk, and minimizing the pharmacotherapy needed for disease control. However, the risk of hypercalcemia should not be neglected.

Conclusion. Despite the increased risk of hypercalcemia, vitamin D supplementation in patients with sarcoidosis should be considered. Each patient’s benefits-to-risks ratio of vitamin D supplementation should be assessed individually and the inter vention should be closely monitored both before and during implementation.

 

Cite

Bieda A, Kondracka M, Bielecki M, Zapałowska A, Kondracki K, Szczepańska M, Kozłowski W. The role of vitamin D and its sup plementation in sarcoidosis – current status. Eur J Clin Exp Med. 2025;23(2):482–492. doi: 10.15584/ejcem.2025.2.16.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited